Literature DB >> 7033115

Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity.

A J van Houte, H Snippe, M G Schmitz, J M Willers.   

Abstract

This paper describes the effect of altering liposomal membrane composition on humoral and cellular immunogenicity of haptenated liposomes in mice. Antibody formation was determined by enumeration of direct, plaque-forming cells in the spleen and delayed-type hypersensitivity (DH) was measured with a footpad swelling test. Humoral immunogenicity of haptenated liposomes was strongly influenced by membrane phospholipid, cholesterol and charged amphiphile composition. Haptenated liposomes prepared from phospholipids with a low (dioleoyl- and dilauroyl-phosphatidylcholine) or high (distearoyl phosphatidylcholine) phase-transition temperature were less immunogenic than those prepared from phospholipids with an intermediate phase-transition temperature (dipalmitoyl phosphatidylcholine and sphingomyelin). In general, increasing the amount of liposomal membrane cholesterol induced a higher humoral response. These results are discussed in relation to liposomal membrane fluidity. Induction of an optimal DH with haptenated liposomes did not occur in the absence of the adjuvant dimethyl dioctadecyl ammonium bromide (DDA). When DDA was used, alterations in membrane composition did not influence cellular immunogenicity. From these results it was concluded that 'intermediate' liposomal membrane fluidity is the most important requirement for induction of optimal antibody formation with haptenated liposomes and that a certain physicochemical configuration of the antigen, provided by the adjuvant DDA, is a prerequisite for induction of DH.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7033115      PMCID: PMC1554971     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

Review 1.  Phase transitions and fluidity characteristics of lipids and cell membranes.

Authors:  D Chapman
Journal:  Q Rev Biophys       Date:  1975-05       Impact factor: 5.318

2.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs.

Authors:  R L Juliano; D Stamp
Journal:  Biochem Biophys Res Commun       Date:  1975-04-07       Impact factor: 3.575

3.  Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins.

Authors:  G Scherphof; F Roerdink; M Waite; J Parks
Journal:  Biochim Biophys Acta       Date:  1978-08-17

4.  The in vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat.

Authors:  L Krupp; A V Chobanian; P I Brecher
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

Review 5.  The function of sterols in membranes.

Authors:  R A Demel; B De Kruyff
Journal:  Biochim Biophys Acta       Date:  1976-10-26

6.  Enhancement of liposomal model membrane immunogenicity by incorporation of lipid A.

Authors:  G F Dancey; T Yasuda; S C Kinsky
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

Review 7.  Thermal analysis of lipids, proteins and biological membranes. A review and summary of some recent studies.

Authors:  B D Ladbrooke; D Chapman
Journal:  Chem Phys Lipids       Date:  1969-12       Impact factor: 3.329

8.  Effect of liposomal model membrane composition on immunogenicity.

Authors:  G F Dancey; T Yasuda; S C Kinsky
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

9.  Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen.

Authors:  A J van Houte; H Snippe; J M Willers
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

10.  Immunogenicity of liposomal model membranes in mice: dependence on phospholipid composition.

Authors:  T Yasuda; G F Dancey; S C Kinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  12 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Design of liposome to improve encapsulation efficiency of gelonin and its effect on immunoreactivity and ribosome inactivating property.

Authors:  A Alam; S R Bhuri; A K Mavila; V Singh
Journal:  Mol Cell Biochem       Date:  1992-06-26       Impact factor: 3.396

3.  Influence of beta-lactam antibiotics and ciprofloxacin on composition and immunogenicity of Escherichia coli outer membrane.

Authors:  H Leying; S Suerbaum; H P Kroll; H Karch; W Opferkuch
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

4.  The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.

Authors:  C A Kraaijeveld; M Schilham; J Jansen; B Benaissa-Trouw; M Harmsen; A J van Houte; H Snippe
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

5.  Enhancement of immunogenicity by incorporation of lipid A into liposomal model membranes and its application to membrane-associated antigens.

Authors:  H Tamauchi; T Tadakuma; T Yasuda; T Tsumita; K Saito
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

6.  Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.

Authors:  O Bakouche; D Gerlier
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

7.  In vitro cellular immune response to measles viral glycoproteins: role of the antigen vector.

Authors:  O Bakouche; B Mougin; D Gerlier
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

Review 8.  Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.

Authors:  Luis O De Serrano; David J Burkhart
Journal:  J Nanobiotechnology       Date:  2017-11-17       Impact factor: 10.435

Review 9.  Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.

Authors:  Aloysious Ssemaganda; Ashwini Kumar Giddam; Mehfuz Zaman; Mariusz Skwarczynski; Istvan Toth; Danielle I Stanisic; Michael F Good
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

Review 10.  The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.

Authors:  Roberto Nisini; Noemi Poerio; Sabrina Mariotti; Federica De Santis; Maurizio Fraziano
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.